Norwalk, Connecticut

Booking Holdings to Present at the 2020 RBC Capital Markets Technology, Internet, Media and Telecommunications Conference

Retrieved on: 
Thursday, November 12, 2020

NORWALK, Conn., Nov. 12, 2020 /PRNewswire/ --Booking Holdings(NASDAQ: BKNG) announced today that Chief Executive Officer Glenn Fogel, and Chief Financial Officer David Goulden will speak at the2020 RBC Capital Markets Technology, Internet, Media and Telecommunications Conference onWednesday, November 18, 2020 beginning at9:35 a.m.

Key Points: 
  • NORWALK, Conn., Nov. 12, 2020 /PRNewswire/ --Booking Holdings(NASDAQ: BKNG) announced today that Chief Executive Officer Glenn Fogel, and Chief Financial Officer David Goulden will speak at the2020 RBC Capital Markets Technology, Internet, Media and Telecommunications Conference onWednesday, November 18, 2020 beginning at9:35 a.m.
  • ET.
  • A live audio cast of the presentation will be available to the public at http://ir.bookingholdings.com .A replay will be available for 14 days.
  • For more information, visit Bookingholdings.com .

Booking Holdings to Make Third Quarter 2020 Earnings Press Release Available on Company's Investor Relations Website on Thursday, November 5

Retrieved on: 
Wednesday, November 4, 2020

NORWALK, Conn., Nov. 4, 2020 /PRNewswire/ -- Third quarter 2020 financial results forBooking Holdings(NASDAQ: BKNG) will be made available at approximately4:00 p.m. ETonThursday, November 5 through a press release posted to the company's Investor Relations website: http://ir.bookingholdings.com .

Key Points: 
  • NORWALK, Conn., Nov. 4, 2020 /PRNewswire/ -- Third quarter 2020 financial results forBooking Holdings(NASDAQ: BKNG) will be made available at approximately4:00 p.m. ETonThursday, November 5 through a press release posted to the company's Investor Relations website: http://ir.bookingholdings.com .
  • Booking Holdingsintends to hold a conference call onThursday, November 5 at4:30 p.m. ETto discuss its third quarter financial results.
  • The event will be webcasted at http://ir.bookingholdings.com .
  • Audio replays will be available on the website for seven days thereafter.

Booking Holdings to Make Third Quarter 2020 Earnings Press Release Available on Company's Investor Relations Website on Thursday, November 5

Retrieved on: 
Monday, October 26, 2020

NORWALK, Conn., Oct. 26, 2020 /PRNewswire/ --Third quarter financial results forBooking Holdings(NASDAQ: BKNG) will be made available at approximately4:00 p.m. ETonThursday, November 5through a press release posted to the company's Investor Relations website: http://ir.bookingholdings.com .

Key Points: 
  • NORWALK, Conn., Oct. 26, 2020 /PRNewswire/ --Third quarter financial results forBooking Holdings(NASDAQ: BKNG) will be made available at approximately4:00 p.m. ETonThursday, November 5through a press release posted to the company's Investor Relations website: http://ir.bookingholdings.com .
  • Booking Holdingsintends to hold a conference call onThursday, November 5at4:30 p.m. ETto discuss its third quarter financial results.
  • Audio replays will be available on the website for seven days thereafter.
  • The mission ofBooking Holdingsis to make it easier for everyone to experience the world.

Despite Pandemic, the Myeloma Community is Succeeding in Advancing Awareness and Raising Funds for Incurable Blood Cancer

Retrieved on: 
Friday, October 2, 2020

Multiple myeloma , or myeloma, is the second most common form of incurable blood cancer.

Key Points: 
  • Multiple myeloma , or myeloma, is the second most common form of incurable blood cancer.
  • The Myeloma Canada community has seen, first-hand, the life-changing impact that advances in myeloma research are having on the lives of those living with this incurable cancer.
  • Multiple myeloma , also known as myeloma, is the second most common form of blood cancer.
  • To learn more, or to donate, please visit www.myeloma.ca .To view "15 Years of Making Myeloma Matter" - Myeloma Canada's 1st Corporate Video, click here .

Choyce Peterson Publishes Mid-Year 2020 Lower Fairfield County Office Space Availability Poster

Retrieved on: 
Tuesday, September 1, 2020

The full-size poster tracks changes in office space availabilities from Year-End 2019 to Mid-Year 2020 in larger, primarily multi-tenanted Class A office buildings in Greenwich, Stamford, Norwalk, and Westport.

Key Points: 
  • The full-size poster tracks changes in office space availabilities from Year-End 2019 to Mid-Year 2020 in larger, primarily multi-tenanted Class A office buildings in Greenwich, Stamford, Norwalk, and Westport.
  • The unique study illustrates the absorption and give back of space, as well as overall availability statistics.
  • Stamford: remained the same at 30.2% as office space absorption and give backs were equalized.
  • Adam Cognetta, vice president at Choyce Peterson continued, "There's much anticipation surrounding the ripple effect from COVID-related factors.

Booking Holdings to Make Second Quarter 2020 Earnings Press Release Available on Company's Investor Relations Website on Thursday, August 6

Retrieved on: 
Wednesday, August 5, 2020

NORWALK, Conn., Aug. 5, 2020 /PRNewswire/ --Second quarter financial results forBooking Holdings(NASDAQ: BKNG) will be made available at approximately4:00 p.m. ETonThursday, August 6through a press release posted to the company's Investor Relations website: http://ir.bookingholdings.com .

Key Points: 
  • NORWALK, Conn., Aug. 5, 2020 /PRNewswire/ --Second quarter financial results forBooking Holdings(NASDAQ: BKNG) will be made available at approximately4:00 p.m. ETonThursday, August 6through a press release posted to the company's Investor Relations website: http://ir.bookingholdings.com .
  • Booking Holdingsintends to hold a conference call onThursday, August 6at4:30 p.m. ETto discuss its second quarter financial results.
  • Audio replays will be available on the website for seven days thereafter.
  • The mission ofBooking Holdingsis to make it easier for everyone to experience the world.

Booking Holdings to Make Second Quarter 2020 Earnings Press Release Available on Company's Investor Relations Website on Thursday, August 6

Retrieved on: 
Tuesday, July 21, 2020

NORWALK, Conn., July 21, 2020 /PRNewswire/ --Second quarter financial results for Booking Holdings (NASDAQ: BKNG) will be made available at approximately 4:00 p.m.

Key Points: 
  • NORWALK, Conn., July 21, 2020 /PRNewswire/ --Second quarter financial results for Booking Holdings (NASDAQ: BKNG) will be made available at approximately 4:00 p.m.
  • ET on Thursday, August 6 through a press release posted to the company's Investor Relations website: http://ir.bookingholdings.com .
  • Booking Holdings intends to hold a conference call on Thursday, August 6 at 4:30 p.m.
  • The mission of Booking Holdings is to make it easier for everyone to experience the world.

Multiple Myeloma Research Foundation (MMRF) Launches CureCloud to Democratize Healthcare for Cancer Patients

Retrieved on: 
Tuesday, July 14, 2020

NORWALK, Conn., July 14, 2020 /PRNewswire/ --The Multiple Myeloma Research Foundation (MMRF) is working to democratize healthcare for cancer patients today with the launch of CureCloud, a first-of-its-kind, direct-to-patient research study, powered by genomic and clinical information from multiple myeloma patients, collected through at-home testing.

Key Points: 
  • NORWALK, Conn., July 14, 2020 /PRNewswire/ --The Multiple Myeloma Research Foundation (MMRF) is working to democratize healthcare for cancer patients today with the launch of CureCloud, a first-of-its-kind, direct-to-patient research study, powered by genomic and clinical information from multiple myeloma patients, collected through at-home testing.
  • The study uses a novel, clinical-grade liquid biopsy next-generation sequencing assay for multiple myeloma.
  • A pioneer in precision medicine, the Multiple Myeloma Research Foundation (MMRF) seeks to find a cure for all multiple myeloma patients by relentlessly pursuing innovations that accelerate the development of precision treatments for cancer.
  • 1MMRF, "Multiple Myeloma Research Foundation (MMRF) Continues to Accelerate Discoveries and Breakthroughs," Multiple Myeloma Research Foundation, December 6, 2019, https://themmrf.org/2019/12/multiple-myeloma-research-foundation-mmrf-co...
    2 MMRF, "Multiple Myeloma in African Americans," Multiple Myeloma Research Foundation, August 26, 2019, https://themmrf.org/2019/08/multiple-myeloma-in-african-americans/

GNS Healthcare Launches Gemini™, the First In Silico Patient for Multiple Myeloma

Retrieved on: 
Thursday, June 25, 2020

CAMBRIDGE, Mass., June 25, 2020 /PRNewswire/ -- GNS Healthcare, an AI-driven precision medicine company, today announced the launch of GeminiTM, the in silico multiple myeloma patient.

Key Points: 
  • CAMBRIDGE, Mass., June 25, 2020 /PRNewswire/ -- GNS Healthcare, an AI-driven precision medicine company, today announced the launch of GeminiTM, the in silico multiple myeloma patient.
  • The in silico patient is a highly accurate computer model of disease progression and drug response at the individual patient level.
  • GNS and MMRF recently announced a five-year collaboration which seeks to answer key questions for multiple myeloma patients.
  • More information about GeminiTM, the in silico patient for multiple myeloma, can be found on the GNS website: https://www.gnshealthcare.com/in-silico-patient/ .

GNS Healthcare and Multiple Myeloma Research Foundation (MMRF) Announce a Five-Year Collaboration to Advance Precision Medicine

Retrieved on: 
Thursday, June 18, 2020

"The mission of the MMRF is to cure each and every multiple myeloma patient.

Key Points: 
  • "The mission of the MMRF is to cure each and every multiple myeloma patient.
  • With a highly diverse patient population, we need a critical mass of high-quality, longitudinal patient data to achieve that mission.
  • "The MMRF has had a tremendous impact on the field and on patients through their data and precision medicine stewardship.
  • GNS Healthcare is an AI-driven precision medicine company developingin silicopatients from real world and clinical data to reveal the complex system of interactions underlying disease progression and drug response.